Lv3
238 积分 2022-01-21 加入
Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial
12小时前
待确认
Outcomes of radiosensitisation in elderly patients with advanced bladder cancer
4天前
已完结
Functional cure of hepatitis B in patients with cancer undergoing immune checkpoint inhibitor therapy
2个月前
已完结
Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial
4个月前
已完结
Stereotactic body radiotherapy versus conventional external beam radiotherapy in patients with painful spinal metastases: an open-label, multicentre, randomised, controlled, phase 2/3 trial
5个月前
已完结
Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial
8个月前
已完结
Updated efficacy and safety data from IMbrave150: Atezolizumab plus bevacizumab vs. sorafenib for unresectable hepatocellular carcinoma
8个月前
已完结
Changing Epidemiology of Hepatocellular Carcinoma Within the United States and Worldwide
8个月前
已完结
Prognostic factors and predictors of sorafenib benefit in patients with hepatocellular carcinoma: Analysis of two phase III studies
8个月前
已完结
Precision treatment in advanced hepatocellular carcinoma
8个月前
已完结
皖公网安备34019202002308
